Skip to main content
. 2020 May 24;8(1):e000696. doi: 10.1136/jitc-2020-000696

Figure 4.

Figure 4

Kaplan-Meier curves for progression-free survival (A) and overall survival (OS) (B) in the apatinib continuous and the intermittent dosing cohorts.